Impact of physicians' beliefs and practices on cholesterol levels in patients with type 2 diabetes: A longitudinal assessment

American Heart Journal

Volumn 149, Issue 1, 2005, Pages 104-111

  Franciosi, Monica ^a   Pellegrini, Fabio ^a   De Berardis, Giorgia ^a   Belfiglio, Maurizio ^a   Di Nardo, Barbara ^a   Greenfield, Sheldon ^b   Kaplan, Sherrie H ^b   Rossi, Maria C E ^a   Sacco, Michele ^a   Tognoni, Gianni ^a   Valentini, Miriam ^a   Nicolucci, Antonio ^a  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OUTCOMES RESEARCH; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUESTIONNAIRE;

ANTILIPEMIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TRIGLYCERIDES;

EID: 19944433586     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.06.011     Document Type: Article

References (28)

1. Kannel W.B., McGee D.L. Diabetes and glucose tolerance as risk factors for cardiovascular disease the Framingham study. Diabetes Care. 2:1997;120-126
2. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444
3. Haffner S.M., Lehto S., Ronnemaa T., et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234
4. Miettinen H., Lehto S., Salomaa V., et al. Impact of diabetes on mortality after the first myocardial infarction the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 21:1998;69-75
5. McGovern P.G., Jacobs D.R. Jr, Shahar E., et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997 the Minnesota heart survey. Circulation. 104:2001;19-24
6. Pyörälä K., Pedersen T.R., Kjekshus J., et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary artery disease a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). [errata appears in Diabetes Care1997;20:1048] Diabetes Care. 20:1997;614-620
7. Goldberg R.B., Mellies M.J., Sacks F.M., et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels subgroup analyses in the cholesterol and recurrent events (CARE) trial: the Care Investigators. Circulation. 98:1998;2513-2519
8. Haffner S.M., Alexander C.M., Cook T.J., et al. Reduced coronary events in simvastatin-treated patients with coronary hearth disease and diabetes or impaired fasting glucose levels subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med. 159:1999;2661-2667
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes a randomised placebo-controlled trial. Lancet. 361:2003;2005-2016
10. Haffner S.M. American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care. 26:(suppl1):2003;S83-86
11. Ansell B.J., Watson K.E., Fogelman A.M. An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines National Cholesterol Education Program. JAMA. 282:1999;2051-2057
12. De Backer G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 24:2003;1601-1610
13. Massing M.W., Foley K.A., Sueta C.A., et al. Trends in lipid management among patients with coronary artery disease has diabetes received the attention it deserves? Diabetes Care. 26:2003;991-997
14. Massing M.W., Henley N.S., Carter-Edwards L., et al. Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care. 26:2003;1369-1373
15. Frolkis J.P., Zyzanski S.J., Schawartz J.M., et al. Physicians noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines. Circulation. 98:1998;851-855
16. Meigs J.B., Strafford R.S. Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes. J Gen Intern Med. 15:2000;220-228
17. Belfiglio M., De Berardis G., Franciosi M., et al. The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group - quality of care and outcomes in type 2 diabetes. Diabetes Care. 24:2001;423-429
18. Franciosi M., Pellegrini F., De Berardis G., et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients an urgent need for better educational strategies. Diabetes Care. 24:2001;1870-1877
19. De Berardis G., Franciosi M., Belfiglio M., et al. Erectile dysfunction and quality of life in type 2 diabetic patients a serious problem too often overlooked. Diabetes Care. 25:2002;284-291
20. Pellegrini F., Belfiglio M., De Berardis G., et al. Role of organizational factors in poor blood pressure control in patients with type 2 diabetes the QuED Study Group - quality of care and outcomes in type 2 diabetes. Arch Intern Med. 163:2003;473-480
21. WoodD, De Backer G, Faergeman O, et al. Prevention of coronary heartdisease in clinical practice: recommendations of the Second Joint TaskForce of European and other Societies on coronary prevention. EurHeart J1998;19:1434-503
22. Snijders T.A.B., Bosker R.J. Multilevel analysis: an introduction to basic and advanced multilevel modeling. 1999;SAGE Publications, London
23. Sullivan L.M., Dukes K.A., Losina E. Tutorial in biostatistics an introduction to hierarchical linear modelling. Stat Med. 18:1999;855-888
24. DeLong E. Hierarchical modeling its time has come. Am Heart J. 145:2003;16-18
25. Bruzzi P., Green S.B., Byar D.P., et al. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 122:1985;904-914
26. LaRosa J.C., He J., Vupputuri S. Effects of statins on risk of coronary disease a meta-analysis of randomized controlled trials. [summary for patients in: J AmGeriatr Soc2002;50:391-3] JAMA. 282:1999;2340-2346
27. Martin M.J., Hulley S.B., Browner W.S., et al. Serum cholesterol, blood pressure, and mortality implications from a cohort of 361,662 men. Lancet. 2:1986;933-936
28. Avanzini F., Corsetti A., Maglione T., et al. Simple, shared guidelines raise the quality of antihypertensive treatment in routine care. Am Heart J. 144:2002;726-732